Real-Life check: does new lung cancer drug live up to trial hype?
NCT ID NCT05683977
Summary
This study is observing how well a drug called durvalumab works for people with advanced small cell lung cancer when used alongside standard chemotherapy in real-world medical settings. It follows 254 patients in France who are already receiving this approved treatment combination as their first line of therapy. The goal is to see how effective and manageable the treatment is for a broader group of patients outside of strict clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Angers, 49933, France
-
Research Site
Argenteuil, 95107, France
-
Research Site
Avignon, 84000, France
-
Research Site
Avignon, 84918, France
-
Research Site
Bayonne, 64100, France
-
Research Site
Bordeaux, 33077, France
-
Research Site
Clermont-Ferrand, 63000, France
-
Research Site
Créteil, 94000, France
-
Research Site
Dijon, 21000, France
-
Research Site
Epagny Metz-Tessy, 74370, France
-
Research Site
Évreux, 27015, France
-
Research Site
Gleizé, 69400, France
-
Research Site
La Roche-sur-Yon, 85925, France
-
Research Site
La Rochelle, 17000, France
-
Research Site
Le Chesnay-Rocquencourt, 78150, France
-
Research Site
Limoges, 87000, France
-
Research Site
Marseille, 13008, France
-
Research Site
Nancy, 54100, France
-
Research Site
Nîmes, 30000, France
-
Research Site
Nîmes, 30900, France
-
Research Site
Osny, 95520, France
-
Research Site
Paris, 75005, France
-
Research Site
Pau, 64000, France
-
Research Site
Rennes, France
-
Research Site
Rouen, 76000, France
-
Research Site
Saint-Etienne, 42100, France
-
Research Site
Saint-Grégoire, 35760, France
-
Research Site
Saint-Quentin, 2321, France
-
Research Site
Toulon, 83000, France
-
Research Site
Toulouse, 31076, France
-
Research Site
Toulouse, 31400, France
-
Research Site
Valenciennes, 59300, France
-
Research Site
Vannes, 56017, France
-
Research Site
Villeurbanne, 69100, France
Conditions
Explore the condition pages connected to this study.